Clinical Innovation & Partnering Congress

Dr Marek Tyl Written by Dr Marek Tyl
Published on 21 December 2016
2 min. read

Taking place on the 8-9th March 2017 in partnership with the Innovation Forum and NIHR, and developed by a cohort of thought leaders at J&J and Lilly this year’s congress marks the 10th anniversary of the world series.

The Clinical Innovation and Partnering Congress will be showcasing disruptive tech, game-changing innovation, novel partnering strategies to deliver clinical trials of the future with patient centricity at its heart.

Topics that will be covered include:

  • M-Health and wearables
  • Patient-centric clinical trials
  • Opportunities for clinical innovation.
  • Relationship management
  • Outsourcing strategies
  • How to future proof your clinical operations.
  • Trials and tribulations

Selected speakers:

  • Eric Low, Chief Executive Officer, Myeloma U.K.
  • Bert Hartog, Director Clinical R and D, R&D Operations – Innovation Leader, Johnson and Johnson
  • Yuri Martina, Vice President Clinical Operations, Shionogi Ltd
  • Stephen Nabarro, Head of Clinical Operations and Data Management Drug Development Office Strategy and Research Funding, Cancer Research UK
  • Jane Rhodes, Senior Director, New Initiatives, Innovation Hub, Biogen
  • Marc Sluijs, Digital health investment advisory, Merck

Date: 8-9 March 2017

Time: 08.00 – 17.00

Venue: Hilton Tower Bridge, London, UK

Register and find out more: www.healthnetworkcommunications.com/conference/innovation-and-partnering/

Share content

Leave a Reply

In order to comment you need to be part of Inno-Forum. If you’re already a member Log in or Register

We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.